Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs

Veterinary Parasitology

Volumn 148, Issue 3-4, 2007, Pages 279-287

  Gokbulut, C ^a   Bilgili, A ^b   Hanedan, B ^b   McKellar, Q A ^c  

^a Faculty of Veterinary Medicine   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Albendazole; Benzimidazoles; Dog; Fenbendazole; Oxfendazole; Pharmacokinetics

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; ANAVERM; ANTHELMINTIC AGENT; CURANTEL; DRUG METABOLITE; FENBENDAZOLE; KLOZAK; OXFENDAZOLE; OXFENDAZOLE SULFONE; UNCLASSIFIED DRUG; VETERINARY DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG POTENCY; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEAN RESIDENCE TIME; NONHUMAN; PARASITE CONTROL;

ADMINISTRATION, ORAL; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; AREA UNDER CURVE; BENZIMIDAZOLES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; FENBENDAZOLE; REPRODUCIBILITY OF RESULTS;

CANIS FAMILIARIS;

EID: 34547947219     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2007.06.028     Document Type: Article

References (40)

1. Alvarez L., Sanchez S., and Lanusse C. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetics behaviour in sheep. J. Vet. Pharmacol. Ther. 22 (1999) 77-86
2. Alvarez L., Imperiale F., Sanchez S., Murno G., and Lanusse C. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Vet. Parasitol. 94 (2000) 75-89
3. Baggot J.D., and McKellar Q.A. The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. J. Vet. Pharmacol. Ther. 17 (1994) 409-419
4. Barr S., Bowman D., Heller R., and Erb H. Efficacy of albendazole against giardasis in dogs. Am. J. Vet. Res. 54 (1993) 926-928
5. Barr S., Bowman D., and Heller R. Efficacy of fenbendazole against giardasis in dogs. Am. J. Vet. Res. 55 (1994) 988-990
6. Benoit E., Besse S., and Delatour P. Effect of repeated doses of albendazole on enantiomerism of its sulphoxide metabolite in goats. Am. J. Vet. Res. 53 (1992) 1663-1665
7. Bourdoiseau G., Cadore J.L., Fournier C., and Gounel J.M. Oslerosis of the dog: diagnostic and therapeutic status. Parasite 1 (1994) 369-378
8. Delatour P., Benoit E., Garnier F., and Besse S. Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep. J. Vet. Pharmacol. Ther. 13 (1990) 361-366
9. Delatour P., Garnier F., Benoit E., and Caude I. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle. Res. Vet. Sci. 50 (1991) 134-138
10. Delatour P., Benoit E., Besse S., and Boukraa A. Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats. Xenobiotica 21 (1991) 217-221
11. Delatour P., Benoit E., and Soraci A. Reckebusch Memorial Lecture: Drug chirality: its significance in veterinary pharmacology and therapeutics. In: Lees P. (Ed). Proceedings of the 6th International Congress of the European Association for Veterinary Pharmacology and Toxicology (1994), Blackwell Scientific Press, Edinburgh 6-9
12. Gemmell M.A., Johnstone P.D., and Oudemans G. The effect of oxfendazole on Echinococcus granulosus and Taenia hydatigena infections in dogs. Res. Vet. Sci. 26 (1979) 389-390
13. Gokbulut, C., 2000. Pharmacokinetic disposition, faecal excretion, metabolism and chirality of anthelmintic drugs in horses. PhD Thesis. University of Glasgow, Faculty of Veterinary Medicine, Department of Pharmacology, Glasgow, Scotland, UK.
14. Gokbulut C., Akar F., and McKellar Q.A. Plasma dispositions and faecal excretions of oxfendazole, fenbendazole and albendazole following oral administration to donkeys. Vet. J. 172 (2006) 166-172
15. Gokbulut C., Cirak V.Y., and Senlik B. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced following oral administration of netobimin in ewes. Vet. Res. Commun. 30 (2006) 791-805
16. Goudah A. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep. Vet. Res. Commun. 27 (2003) 555-566
17. Gyurik R.J., Chow A.W., Zaber B., Brunner E.L., Miller J.A., Villani A.J., Petra L.A., and Parish R.C. The metabolism of albendazole in cattle, sheep, rats and mice. Drug Metab. Dispos. 9 (1981) 503-508
18. Jacobs D. Anthelmintics for dogs and cats. Int. J. Parasitol. 17 (1987) 511-518
19. Lacey E., Brady R.L., Prichard R.K., and Watson T.R. Comparison of inhibition of polymerisation of mammalian tubulin and helminth oocidal activity by benzimidazole carbamates. Vet. Parasitol. 23 (1987) 105-119
20. Landoni M.F., Soraci A.L., Delatour P., and Lees P. Enantioselective behaviour of drugs used in domestic animals: a review. J. Vet. Pharmacol. Ther. 20 (1997) 1-16
21. Lanusse C.E., and Prichard R.K. Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Vet. Parasitol. 49 (1993) 123-158
22. Lubega G.W., and Prichard R.K. Specific interaction of benzimidazole anthelmintics with tubulin: high-affinity binding and benzimidazole resistance in Haemonchus contortus. Mol. Biochem. Parasitol. 38 (1990) 221-232
23. Lubega G.W., and Prichard R.K. Specific interaction of benzimidazole anthelmintics with tubulin from developing stages of thiabendazole-susceptible and -resistant Haemonchus contortus. Biochem. Pharmacol. 41 (1991) 93-101
24. Lubega G.W., and Prichard R.K. Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy. Exp. Parasitol. 73 (1991) 203-213
25. Lui C.Y., Amidon G.L., Berardi R.R., Fleisher D., Youngberg C., and Dressman J.B. Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans. J. Pharm. Sci. 75 (1986) 271-274
26. Marriner S.E., and Bogan J.A. Pharmacokinetics of albendazole in sheep. Am. J. Vet. Res. 41 (1980) 483-491
27. Marriner S.E., and Bogan J.A. Pharmacokinetics of fenbendazole in sheep. Am. J. Vet. Res. 42 (1981) 1146-1148
28. Martin R.J. Modes of action of anthelmintic drugs. Vet. J. 154 (1997) 11-34
29. McKellar Q.A., and Scott E.W. The benzimidazole anthelmintic agents: a review. J. Vet. Pharmacol. Ther. 13 (1990) 223-247
30. McKellar Q., Harrison P., Galbraith E., and Inglis I. Pharmacokinetics of fenbendazole in dogs. J. Vet. Pharmacol. Ther. 13 (1990) 386-392
31. McKellar Q., Galbraith E., and Baxter P. Oral absorption and bioavailability of fenbendazole in the dog and the effects of concurrent ingestion of food. J. Vet. Pharmacol. Ther. 13 (1993) 223-227
32. McKellar Q., Gokbulut C., Muzandu K., and Benchaoui H. Fenbendazole pharmacokinetics, metabolism and potentiation in horses. Drug Metab. Dispos. 30 (2002) 1230-1239
33. Moroni P., Buronfosse T., Longin-Sauvageon C., Delatour P., and Benoit E. Chiral sulphoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes. Drug Metab. Dispos. 23 (1995) 160-165
34. Ngomuo, A.J., 1983. Pharmacokinetic studies of fenbendazole and oxfendazole in cattle. MVM Thesis. University of Glasgow, UK, pp. 72-89.
35. Sanchez S., Alvarez L., Pis A., Quiroga M., and Lanusse C. Differences in plasma and abomasal kinetics of albendazole and its metabolites in calves grazed on pasture or fed a grain-based diet. Res. Vet. Sci. 66 (1999) 223-230
36. Sanchez S., Sallovitz J., Savio E., McKellar Q., and Lanusse C. Comparative plasma bioavailability of two dosage forms of albendazole in dogs. Vet. J. 160 (2000) 150-153
37. Sanchez S., Jones D.G., and McKellar Q.A. Pharmacological approaches towards rationalizing the use of endoparasitic drugs in small animals. J. Vet. Pharmacol. Ther. 29 (2006) 443-457
38. Stoye M. Biology, pathogenicity, diagnosis and control of Ancylostoma caninum. Dtsch Tierarztl Wochenschr. 99 (1992) 315-321
39. Villeneuve V., Beugnet F., and Bourdoiseau G. Efficacy of oxfendazole for the treatment of giardiosis in dogs. Exp. Dog Breeding Kennels Parasite. 7 (2000) 221-226
40. Zajac A., LaBranche T., Donoghue A., and Chu T. Efficacy of fenbendazole in the treatment of experimental giardia infection in dogs. Am. J. Vet. Res. 59 (1998) 61-63